Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,680.00
Bid: 2,680.00
Ask: 2,682.00
Change: -8.00 (-0.30%)
Spread: 2.00 (0.075%)
Open: 2,690.00
High: 2,692.00
Low: 2,670.00
Prev. Close: 2,688.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of Issue of Notes

20 Feb 2024 16:01

RNS Number : 8158D
Coca-Cola HBC AG
20 February 2024

FOR IMMEDIATE RELEASE

Coca-Cola HBC Finance B.V.

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(a company incorporated with limited liability in Switzerland)

Pricing of Issue of Notes

Zug, Switzerland and Amsterdam, The Netherlands - 20 February 2024 - Further to the announcement earlier today, Coca-Cola HBC Finance B.V. (the "Issuer") and Coca-Cola HBC AG ("Coca-Cola HBC") announce the pricing of a ?600 million aggregate principal amount of 3.375% Notes due 2028, to be issued by the Issuer under its ?5,000,000,000 Euro Medium Term Note Programme.

The Notes will be guaranteed by Coca-Cola HBC.

This announcement must be read in conjunction with the Base Prospectus dated 19 December 2023, as supplemented on 15 February 2024 (the "Base Prospectus"), which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

Application will be made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the Regulated Market of the London Stock Exchange plc. Settlement and the issue of the Notes are expected to occur on 27 February 2024.

Disclaimer

Neither this announcement nor the Base Prospectus constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

Please note that the information contained in this announcement and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in this announcement and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in this announcement and/or the Base Prospectus is not addressed. Prior to relying on the information contained in this announcement and/or the Base Prospectus you must ascertain from this announcement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

Enquiries

Coca?Cola HBC Group

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Virginia Phillips

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager

Tel: +44 7597 562 978

claire.evans@cchellenic.com

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IODURVVRSWUUUAR
Date   Source Headline
19th May 201510:15 amBUSMarket overview: US housing starts surge in April
18th May 20159:04 amBUSMarket overview: FTSE 100 finishes up just 0.1%
15th May 20157:00 amRNSTRADING IN LINE WITH EXPECTATIONS
1st May 201510:47 amRNSAnnual Financial Report
1st May 20158:27 amRNSIssue of Equity and Total Voting Rights
30th Apr 20159:51 amRNSBlocklisting Interim Review
20th Apr 20152:26 pmRNSNotice of Results
20th Mar 201510:04 amRNS2014 Integrated Annual Report
2nd Mar 20155:49 pmRNSSupplementary Prospectus
2nd Mar 20154:08 pmRNSSupplementary Prospectus dated March 2, 2015
26th Feb 20152:20 pmRNSDirector/PDMR Shareholding
20th Feb 201510:26 amRNSAthens Exchange trading date from stock options
18th Feb 20157:00 amRNSDELIVERING RESULTS THROUGH OPERATIONAL FOCUS
22nd Jan 20152:00 pmRNSNotice of Results
2nd Jan 20159:09 amRNSIssue of Equity and Total Voting Rights
11th Dec 201411:08 amRNSDirector/PDMR Shareholding
1st Dec 20147:25 amRNSIssue of Equity and Total Voting Rights
11th Nov 20141:32 pmRNSSupplementary Base Prospectus dated November 11, 2
11th Nov 20141:22 pmRNSPublication of supplementary prospectus
6th Nov 20147:00 amRNSSOLID PERFORMANCE DESPITE VOLUME PRESSURE
3rd Nov 20147:03 amRNSIssue of Equity and Total Voting Rights
7th Oct 20141:07 pmRNSNotice of Results
1st Oct 20142:36 pmRNSDirector/PDMR Shareholding
1st Oct 20147:16 amRNSIssue of Equity and Total Voting Rights
18th Sep 20143:49 pmRNSPublication of Base Prospectus
17th Sep 201410:06 amRNSCOCA-COLA HBC NAMED INDUSTRY LEADER IN THE DJSI
11th Sep 20141:58 pmRNSDirector/PDMR Shareholding
2nd Sep 20147:55 amRNSDirector Declaration
20th Aug 201410:30 amRNSResults for the six months ended June 27, 2014
11th Aug 20147:00 amRNS2014 Half Yearly Financial Report
7th Aug 20147:00 amRNSROBUST PERFORMANCE IN DIFFICULT MARKET CONDITIONS
1st Aug 20147:52 amRNSIssue of equity and total voting rights
24th Jul 20143:32 pmRNSAthens Exchange trading date from stock options
14th Jul 20148:51 amRNSNotice of Results
30th Jun 20147:09 amRNSIntention to delist from the NYSE
27th Jun 20142:21 pmRNSDirectorate Change
26th Jun 20149:45 amRNSResult of AGM
12th Jun 201410:07 amRNSDirector/PDMR Shareholding
2nd Jun 201410:23 amRNSIssue of Equity and Total Voting Rights
28th May 20149:20 amRNSNotice of AGM
28th May 20149:00 amRNSBoard of Directors change and dividend dates
23rd May 20142:23 pmRNSDirector/PDMR Shareholding
16th May 20147:00 amRNSFY EXPECTATIONS UNCHANGED DESPITE CHALLENGING QTR
1st May 20148:00 amRNSIssue of Equity and Total Voting Rights
30th Apr 20148:11 amRNSBlocklisting Interim Review
23rd Apr 20141:34 pmRNSNotice of Results
1st Apr 20147:51 amRNSIssue of Equity and Total Voting Rights
31st Mar 20144:03 pmRNSFiling with the U.S.SEC
31st Mar 20142:29 pmRNSAnnual Financial Report
13th Mar 201412:20 pmRNSSupplementary prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.